Searchable abstracts of presentations at key conferences in endocrinology

ea0035p396 | Diabetes (epidemiology, pathophysiology) | ECE2014

Vitamin D and diabetes mellitus type 2

Kostoglou-Athanassiou Ifigenia , Athanassiou Panagiotis , Gkountouvas Anastasios , Kaldrymides Philippos

Vitamin D deficiency has been observed in diabetes mellitus type 2 patients. It has been found to be related to poor glycemic control in diabetes mellitus type 2 patients as well as in patients with gestational diabetes. The administration of vitamin D in diabetes mellitus type 2 patients with vitamin D deficiency has been found to have conflicting results on blood glucose control. The aim was to assess the effect of vitamin D administration in diabetes mellitus type 2 patient...

ea0035p161 | Calcium and Vitamin D metabolism | ECE2014

Cinacalcet in the treatment of primary hyperparathyroidism

Kostoglou-Athanassiou Ifigenia , Xanthakou Eleni , Athanassiou Panagiotis , Gkountouvas Anastasios , Kaldrymides Philippos

Primary hyperparathyroidism is currently recognized with increasing frequency by routine calcium measurement in biochemical examinations. Primary hyperparathyroidism may be due to a parathyroid adenoma, parathyroid hyperplasia and, rarely, parathyroid carcinoma. Cinacalcet is used in the medical management of primary hyperparathyroidism.The aim was to assess the role of cinacalcet in the treatment of primary hyperparathyroidism.Pat...

ea0032p134 | Calcium and Vitamin D metabolism | ECE2013

Primary hyperparathyroidism and vitamin D deficiency. therapeutic implications

Kostoglou-Athanassiou Ifigenia , Athanassiou Panagiotis , Gkountouvas Anastasios , Xanthakou Eleni , Keramidas Ioannis , Chatjimarkou Fotini , Kaldrymidis Philippos

Primary hyperparathyroidism is a rather frequent disorder characterized by high plasma PTH and calcium. Vitamin D deficiency is prevalent in all areas of the world. Vitamin D deficiency has been described in patients with primary hyperparathyroidism. When present, vitamin D deficiency may be associated with large size parathyroid adenomas and musculoskeletal pain.The aim was to describe two cases of primary hyperparathyroidism and vitamin D deficiency.</...

ea0032p172 | Cardiovascular Endocrinology &amp; Lipid Metabolism | ECE2013

Lipid levels in acromegaly

Kostoglou-Athanassiou Ifigenia , Gkountouvas Anastasios , Keramidas Ioannis , Xanthakou Eleni , Chatjimarkou Fotini , Kaldrymidis Philippos

Acromegaly is known to be associated with increased cardiovascular risk. Additionally, acromegaly is known to be associated with disordered carbohydrate metabolism. Lipid levels in acromegaly have not been extensively studied. The aim was to study lipid levels in acromegaly.Methods: In 32 patients with newly diagnosed acromegaly lipid levels were studied. In particular total cholesterol, HDL cholesterol, LDL cholesterol and triglyceride levels were measu...

ea0032p199 | Cardiovascular Endocrinology &amp; Lipid Metabolism | ECE2013

Lipid levels in patients with rheumatoid arthritis and the effect of rituximab

Kostoglou-Athanassiou Ifigenia , Xanthakou Eleni , Tzanavari Aikaterini , Gkountouvas Anastasios , Dadiras Nicolaos , Koutsika Eirini , Athanassiou Panagiotis

Rheumatoid arthritis (RA) is known to be associated with cardiovascular comorbidity. In particular, patients with RA are known to be at increased for the development of atherosclerosis. Treatment with biological agents in RA may affect lipid levels.Aim: The aim was to study the effect of rituximab treatment on lipid levels in RA patients.Methods: In a cohort of 20 patients with RA lipid levels were studied before, 6 and 12 months a...

ea0016p299 | Endocrine tumours | ECE2008

Adrenal ganglioneuroma: a new cause of increased serum calcitonin

Bakola Theodosia , Gkountouvas Anastasios , Aggelopoulou Anastasia , Tertipi Athanasia , Pappas Anastasios , Iakovidou Ioanna , Nisiotis Athanasios , Kaldrimidis Philippos

Introduction: Ganglioneuromas are rare, benign tumors of mature ganglion cells, arising from the sympathetic ganglia and 20% are located in the adrenal medulla, representing 1–4% of adrenal incidentalomas. About 1/3 secrete catecholamines but hypertension and other adrenergic symptoms are rare. About 60% are depicted with 131I- MIBG.Case report: A 72-year-old man was admitted for a left adrenal tumor 9×8 cm, incidentally found in abd...

ea0022p445 | Endocrine tumours &amp; neoplasia (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

The use of receptor tyrosine kinase inhibitors in metastatic differentiated thyroid carcinoma

Gkountouvas Anastasios , Kostoglou-Athanassiou Ifigenia , Veniou Eirini , Thomas Dimitrios , Aggelopoulou Anastasia , Nikas Marios , Ziras Nicolaos , Kaldrymides Philippos

The management of metastatic differentiated thyroid carcinoma included until recently the use of therapeutic 131I, radiotherapy and in specific cases chemotherapy. However, recently new agents entered in the management of differentiated metastatic thyroid carcinoma which aim at specific cell receptors and inhibit the growth of the carcinoma in a specific and targeted way.The aim was to present the experience of the use of the receptor tyrosine...

ea0022p854 | Thyroid | ECE2010

Differentiated thyroid carcinoma in young adults

Gkountouvas Anastasios , Kostoglou-Athanassiou Ifigenia , Pappas Anastasios , Veniou Eirini , Nikas Marios , Aggelopoulou Anastasia , Thomas Dimitrios , Kaldrymides Philippos

Differentiated thyroid carcinoma represents a small percentage of human carcinomas. However, it is the commonest endocrine neoplasm and if diagnosed and treated properly does not affect the long-term survival of the patients.Aim: The aim was to study differentiated thyroid carcinoma affecting young adults.Patients and methods: All patients presenting with thyroid carcinoma to the department from 01.01.2002 to 31.12.2008 were review...